Palvella Therapeutics, Inc.
Status: Publicly traded
Direct answer
Palvella Therapeutics, Inc. is publicly traded on NASDAQ under the ticker PVLA.
Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for patients afflicted with severe and uncommon inherited skin conditions. Central to its pipeline is QTORIN 3.9% rapamycin anhydrous gel (referred to as QTORIN rapamycin), which is currently undergoing Phase 3 clinical trials for microcystic lymphatic...
Can you invest in Palvella Therapeutics, Inc.?
Yes. Palvella Therapeutics, Inc. is publicly traded on NASDAQ under the ticker PVLA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Palvella Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.